---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-024773"
form_type: "8-K"
ticker: "TBLA"
cik: "0001840502"
company_name: "Taboola.com Ltd."
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T13:02:46.904384+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Taboola Q1 beats high end of all guidance; revenue +26% YoY to $414M, reiterates FY 2024 outlook

## Summary
- Revenue $414M (+26% YoY), Gross profit $109M, ex-TAC Gross Profit $138.9M, Net loss $26.2M.
- Adjusted EBITDA $23.5M (+132% YoY), Free Cash Flow $26.8M (+140% YoY).
- Q2 guidance: Revenue $410-440M (+28% YoY), Adjusted EBITDA $20-30M (+60% YoY).
- FY 2024 guidance reiterated: Revenue ~$1.9B (+33% YoY), Adj. EBITDA $200M+, FCF $100M+.
- Repurchased $28M in shares in Q1; $92M remains under buyback authorization (~7% of market cap).

## SEC filing metadata
- accession: 0001140361-24-024773
- form_type: 8-K
- ticker: TBLA
- cik: 0001840502
- company_name: Taboola.com Ltd.
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840502/000114036124024773/0001140361-24-024773-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840502/000114036124024773/ef20028228_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-024773
- JSON: https://secwatch.observer/filing/0001140361-24-024773.json
- Plain text: https://secwatch.observer/filing/0001140361-24-024773.txt

## Key facts
- Earnings Releases
  Taboola.com Ltd. reported the first quarter of 2024 results: revenue $414.0M, net income Net loss of $26.2M, EPS $(0.08). Guidance reaffirmed.
  - Period: the first quarter of 2024
  - Revenue: $414.0M
  - Net income: Net loss of $26.2M
  - EPS: $(0.08)
  - Guidance: reaffirmed
  - Result: reported results
  source text: and Expects Accelerating Growth Across All Key Metrics Q1 2024 and FY 2024 Key Highlights Q1 Financials - beat high end of guidance across all key metrics - Q1 2024 Revenues $414M, Gross profit $109M, ex-TAC Gross Profit $139M, Net loss $26M, Non-GAAP Net Income $4M, Adj. EBITDA $23M, Free Cash Flow $27M - Accelerating YoY growth: Revenues +26%, ex-TAC
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840502/000114036124024773/0001140361-24-024773-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
